BridgeMD
New treatment option for Heart Failure With Preserved Ejection Fraction
Official title The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction
ClinicalTrials.gov ID: NCT05878912
What this study is testing
- What it's testing
- This study looks at the effects of weight loss in people who have heart failure with preserved ejection fraction (HFpEF) and are overweight or obese. The main questions it aims to answer are whether weight loss in this group of people improves: 1.
- Time commitment: about 8 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Heart failure with preserved ejection fraction (HFpEF)
- Left ventricular ejection fraction (LVEF) =/\> 50%
- Body Mass Index (BMI) approximately =/\> 27.5 kg/m\^2
You likely can't join if
- Contraindications to magnetic resonance imaging
- NYHA class IV
- Significant valvular, ischemic, infiltrative or other potentially confounding cardiac disease
- Pregnancy, planned pregnancy or lactating
- Any other conditions which may potentially compromise the safety or scientific validity of the study
The study team makes the final eligibility decision.
Where it's taking place
- Oxford, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oxford, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.